Safety, tolerability, pharmacodynamics and pharmacokinetics following once-daily doses of BI 187004, an inhibitor of 11 beta-hydroxysteroid dehydrogenase-1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity.
Diabetes Obes Metab
; 25(3): 832-843, 2023 03.
Article
en En
| MEDLINE
| ID: mdl-36478142
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Diabetes Mellitus Tipo 2
/
Metformina
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Humans
Idioma:
En
Año:
2023
Tipo del documento:
Article